HUP0102305A2 - Hatóanyagok bedolgozása hordozó mátrixokba - Google Patents

Hatóanyagok bedolgozása hordozó mátrixokba

Info

Publication number
HUP0102305A2
HUP0102305A2 HU0102305A HUP0102305A HUP0102305A2 HU P0102305 A2 HUP0102305 A2 HU P0102305A2 HU 0102305 A HU0102305 A HU 0102305A HU P0102305 A HUP0102305 A HU P0102305A HU P0102305 A2 HUP0102305 A2 HU P0102305A2
Authority
HU
Hungary
Prior art keywords
incorporation
active substances
carrier matrixes
matrixes
carrier
Prior art date
Application number
HU0102305A
Other languages
English (en)
Inventor
Marie-Louise Andersson
Catherine Boissier
Anne Marie Juppo
Anette Larsson
Original Assignee
Astrazeneca Ab,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, filed Critical Astrazeneca Ab,
Publication of HUP0102305A2 publication Critical patent/HUP0102305A2/hu
Publication of HUP0102305A3 publication Critical patent/HUP0102305A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nozzles (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
HU0102305A 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes HUP0102305A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes
PCT/SE1999/000583 WO1999052507A1 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes

Publications (2)

Publication Number Publication Date
HUP0102305A2 true HUP0102305A2 (hu) 2001-12-28
HUP0102305A3 HUP0102305A3 (en) 2003-04-28

Family

ID=20410946

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102305A HUP0102305A3 (en) 1998-04-14 1999-04-09 Incorporation of active substances in carrier matrixes

Country Status (31)

Country Link
US (1) US6372260B1 (hu)
EP (1) EP1069890B1 (hu)
JP (1) JP2002511400A (hu)
KR (1) KR100600691B1 (hu)
CN (1) CN1201728C (hu)
AR (1) AR019262A1 (hu)
AT (1) ATE329580T1 (hu)
AU (1) AU744874B2 (hu)
BR (1) BR9909636A (hu)
CA (1) CA2327522C (hu)
CY (1) CY1105154T1 (hu)
CZ (1) CZ20003784A3 (hu)
DE (1) DE69931904T2 (hu)
DK (1) DK1069890T3 (hu)
EE (1) EE200000595A (hu)
ES (1) ES2267268T3 (hu)
HU (1) HUP0102305A3 (hu)
ID (1) ID29286A (hu)
IL (1) IL138635A0 (hu)
IS (1) IS5656A (hu)
NO (1) NO329145B1 (hu)
NZ (1) NZ507190A (hu)
PL (1) PL344077A1 (hu)
PT (1) PT1069890E (hu)
RU (1) RU2208435C2 (hu)
SE (1) SE9801287D0 (hu)
SK (1) SK14112000A3 (hu)
TR (1) TR200002960T2 (hu)
TW (1) TW542724B (hu)
WO (1) WO1999052507A1 (hu)
ZA (1) ZA992549B (hu)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1242112A4 (en) * 1999-12-21 2005-02-09 Rxkinetix Inc PRODUCTS CONTAINING MEDICINANT SUBSTANCE PARTICLES AND PROCESS FOR PREPARING THE SAME
US6761909B1 (en) * 1999-12-21 2004-07-13 Rxkinetix, Inc. Particulate insulin-containing products and method of manufacture
GB0102075D0 (en) 2001-01-26 2001-03-14 Astrazeneca Ab Process
FR2824754B1 (fr) * 2001-05-15 2004-05-28 Separex Sa Procede d'obtention de particules solides a partir d'au moins un produit hydrosoluble
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
JP5041651B2 (ja) * 2001-09-28 2012-10-03 ティーエヌティーギャンブル・インコーポレーテッド 生物体成分の送達系
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
GB0216780D0 (en) * 2002-07-19 2002-08-28 Bradford Particle Design Ltd Methods of particle formation
US6966990B2 (en) 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
US7083748B2 (en) * 2003-02-07 2006-08-01 Ferro Corporation Method and apparatus for continuous particle production using supercritical fluid
US6931888B2 (en) 2003-02-07 2005-08-23 Ferro Corporation Lyophilization method and apparatus for producing particles
US7455797B2 (en) * 2003-02-28 2008-11-25 Ferro Corporation Method and apparatus for producing particles using supercritical fluid
WO2004096405A1 (en) * 2003-04-29 2004-11-11 Akzo Nobel N.V. Antisolvent solidification process
CA2524773C (en) 2003-05-08 2014-04-08 Nektar Therapeutics Uk Ltd Particulate coformulations of active substances with excipients
US20060008531A1 (en) * 2003-05-08 2006-01-12 Ferro Corporation Method for producing solid-lipid composite drug particles
WO2005022603A2 (en) * 2003-09-02 2005-03-10 Integral Technologies, Inc. Low cost conductive containers manufactured from conductive loaded resin-based materials
GB0602637D0 (en) * 2006-02-09 2006-03-22 Glaxo Group Ltd Novel process
NL1031224C2 (nl) * 2006-02-23 2007-09-03 Friesland Brands Bv Het bereiden van gedroogde deeltjes met behulp van een superkritisch medium.
US20080095856A1 (en) * 2006-05-12 2008-04-24 Jacobson Gunilla B Encapsulated Nanoparticles for Drug Delivery
FR2900845B1 (fr) * 2006-05-15 2009-03-06 Commissariat Energie Atomique Procede et dispositif de synthese de particules organiques ou inorganiques enrobees
EP1913955A1 (en) 2006-10-19 2008-04-23 Gerhard, Markus Novel method for treating H.pylori infections
US7745566B2 (en) * 2007-01-23 2010-06-29 Ferro Corporation Methods for the purification of polymers
US20080260852A1 (en) * 2007-01-23 2008-10-23 Ferro Pfanstiehl Laboratories, Inc. Supercritical fluid extraction produced by in-line homogenization
ES2538082T3 (es) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
KR102170146B1 (ko) * 2019-03-05 2020-10-26 서울대학교산학협력단 Pca 공정을 이용한 배양액의 결정화 장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639441A (en) 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation

Also Published As

Publication number Publication date
CZ20003784A3 (cs) 2001-08-15
SE9801287D0 (sv) 1998-04-14
NO329145B1 (no) 2010-08-30
TR200002960T2 (tr) 2000-12-21
EE200000595A (et) 2002-04-15
IL138635A0 (en) 2001-10-31
AU4066399A (en) 1999-11-01
NO20005150L (no) 2000-12-08
KR20010042660A (ko) 2001-05-25
PL344077A1 (en) 2001-09-24
IS5656A (is) 2000-10-11
AR019262A1 (es) 2002-02-13
CA2327522C (en) 2008-03-25
BR9909636A (pt) 2000-12-19
HUP0102305A3 (en) 2003-04-28
DE69931904D1 (de) 2006-07-27
PT1069890E (pt) 2006-09-29
RU2208435C2 (ru) 2003-07-20
EP1069890B1 (en) 2006-06-14
NO20005150D0 (no) 2000-10-13
CN1309555A (zh) 2001-08-22
AU744874B2 (en) 2002-03-07
ID29286A (id) 2001-08-16
ATE329580T1 (de) 2006-07-15
ZA992549B (en) 1999-10-14
CA2327522A1 (en) 1999-10-21
WO1999052507A1 (en) 1999-10-21
DK1069890T3 (da) 2006-08-28
CN1201728C (zh) 2005-05-18
DE69931904T2 (de) 2006-12-21
CY1105154T1 (el) 2010-03-03
EP1069890A1 (en) 2001-01-24
NZ507190A (en) 2002-02-01
US6372260B1 (en) 2002-04-16
KR100600691B1 (ko) 2006-07-19
SK14112000A3 (sk) 2001-07-10
ES2267268T3 (es) 2007-03-01
TW542724B (en) 2003-07-21
JP2002511400A (ja) 2002-04-16

Similar Documents

Publication Publication Date Title
IL138635A0 (en) Incorporation of active substances in carrier matrixes
HUP0104578A3 (en) Nonsteroidal antiinflammatories and compounds being their active ingredients
IN1998CH01442A (en) Microparticles containing agricultural active ingredients
HUP0001682A3 (en) Fungicide active substance combinations
EP1024796A4 (en) POLYMERS CONTAINING ANTIMICROBIAL AGENTS AND METHODS OF MAKING AND USING THE SAME
PL322494A1 (en) Compounds and compositions intended to provide active substances
PL339864A1 (en) Preparation containing 2-methylthiene benzodiazepin
TW399786U (en) Improvememt of receptacle structure
PL336693A1 (en) Novel method of obtaining farmacologically active substances
PL326526A1 (en) Compositions of controllable release of active substances contained in them
GR3035382T3 (en) Active substance combinations comprising pyrethroids and insect-development inhibitors
EP1067130A4 (en) TRIAZOLO DERIVATIVES, AND CHIMIOKIN INHIBITORS CONTAINING THESE DERIVATIVES AS ACTIVE INGREDIENT
GB9827964D0 (en) Active backplane circuitry
AU3240000A (en) Hydrophobic and particulate soil removal composition
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
EP1148107A4 (en) COATED BIOLOGICALLY ACTIVE GRAINS
IL138841A (en) Composition in the form of extruded granules containing an organosilicone surfactant and an active ingredient
PL349393A1 (en) Sulphonyloxazolamines as therapeutic active ingredients
HUP0104866A3 (en) Organo-phosphorus compounds and their utilization
SI1069890T1 (sl) Vkljucitev aktivnih substanc v matriko nosilca
GB9807586D0 (en) Enzymes and their use
GB9603431D0 (en) Immunodulating active substance
HUP0102002A3 (en) Biologically active composition and process for its preparation
AU1558700A (en) Combinations of active ingredients
GB9827901D0 (en) Active semiconductor